These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 19712078)
1. The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli. Thanabalasuriar A; Koutsouris A; Weflen A; Mimee M; Hecht G; Gruenheid S Cell Microbiol; 2010 Jan; 12(1):31-41. PubMed ID: 19712078 [TBL] [Abstract][Full Text] [Related]
2. The inhibition of COPII trafficking is important for intestinal epithelial tight junction disruption during enteropathogenic Escherichia coli and Citrobacter rodentium infection. Thanabalasuriar A; Kim J; Gruenheid S Microbes Infect; 2013; 15(10-11):738-44. PubMed ID: 23747681 [TBL] [Abstract][Full Text] [Related]
3. The bacterial virulence factor NleA inhibits cellular protein secretion by disrupting mammalian COPII function. Kim J; Thanabalasuriar A; Chaworth-Musters T; Fromme JC; Frey EA; Lario PI; Metalnikov P; Rizg K; Thomas NA; Lee SF; Hartland EL; Hardwidge PR; Pawson T; Strynadka NC; Finlay BB; Schekman R; Gruenheid S Cell Host Microbe; 2007 Sep; 2(3):160-71. PubMed ID: 18005731 [TBL] [Abstract][Full Text] [Related]
4. The bacterial virulence factor NleA's involvement in intestinal tight junction disruption during enteropathogenic E. coli infection is independent of its putative PDZ binding domain. Thanabalasuriar A; Koutsouris A; Hecht G; Gruenheid S Gut Microbes; 2010 Mar; 1(2):114-118. PubMed ID: 21326920 [TBL] [Abstract][Full Text] [Related]
6. Enteropathogenic E. coli-induced barrier function alteration is not a consequence of host cell apoptosis. Viswanathan VK; Weflen A; Koutsouris A; Roxas JL; Hecht G Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1165-70. PubMed ID: 18356531 [TBL] [Abstract][Full Text] [Related]
7. Tricellular Tight Junction Protein Tricellulin Is Targeted by the Enteropathogenic Escherichia coli Effector EspG1, Leading to Epithelial Barrier Disruption. Morampudi V; Graef FA; Stahl M; Dalwadi U; Conlin VS; Huang T; Vallance BA; Yu HB; Jacobson K Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795363 [TBL] [Abstract][Full Text] [Related]
8. Enteropathogenic E. coli effectors EspF and Map independently disrupt tight junctions through distinct mechanisms involving transcriptional and post-transcriptional regulation. Singh AP; Sharma S; Pagarware K; Siraji RA; Ansari I; Mandal A; Walling P; Aijaz S Sci Rep; 2018 Feb; 8(1):3719. PubMed ID: 29487356 [TBL] [Abstract][Full Text] [Related]
9. Enteropathogenic Escherichia coli Uses NleA to Inhibit NLRP3 Inflammasome Activation. Yen H; Sugimoto N; Tobe T PLoS Pathog; 2015 Sep; 11(9):e1005121. PubMed ID: 26332984 [TBL] [Abstract][Full Text] [Related]
10. Tandem tyrosine phosphosites in the Enteropathogenic Escherichia coli chaperone CesT are required for differential type III effector translocation and virulence. Runte CS; Jain U; Getz LJ; Secord S; Kuwae A; Abe A; LeBlanc JJ; Stadnyk AW; Kaper JB; Hansen AM; Thomas NA Mol Microbiol; 2018 Jun; 108(5):536-550. PubMed ID: 29509331 [TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function. Viswanathan VK; Koutsouris A; Lukic S; Pilkinton M; Simonovic I; Simonovic M; Hecht G Infect Immun; 2004 Jun; 72(6):3218-27. PubMed ID: 15155623 [TBL] [Abstract][Full Text] [Related]
12. Tight Junction Disruption Induced by Type 3 Secretion System Effectors Injected by Enteropathogenic and Enterohemorrhagic Escherichia coli. Ugalde-Silva P; Gonzalez-Lugo O; Navarro-Garcia F Front Cell Infect Microbiol; 2016; 6():87. PubMed ID: 27606286 [TBL] [Abstract][Full Text] [Related]
13. A C-terminal class I PDZ binding motif of EspI/NleA modulates the virulence of attaching and effacing Escherichia coli and Citrobacter rodentium. Lee SF; Kelly M; McAlister A; Luck SN; Garcia EL; Hall RA; Robins-Browne RM; Frankel G; Hartland EL Cell Microbiol; 2008 Feb; 10(2):499-513. PubMed ID: 17979986 [TBL] [Abstract][Full Text] [Related]
14. EspF Interacts with nucleation-promoting factors to recruit junctional proteins into pedestals for pedestal maturation and disruption of paracellular permeability. Peralta-Ramírez J; Hernandez JM; Manning-Cela R; Luna-Muñoz J; Garcia-Tovar C; Nougayréde JP; Oswald E; Navarro-Garcia F Infect Immun; 2008 Sep; 76(9):3854-68. PubMed ID: 18559425 [TBL] [Abstract][Full Text] [Related]
17. Retraction of enteropathogenic E. coli type IV pili promotes efficient host cell colonization, effector translocation and tight junction disruption. Aroeti B; Friedman G; Zlotkin-Rivkin E; Donnenberg MS Gut Microbes; 2012; 3(3):267-71. PubMed ID: 22572833 [TBL] [Abstract][Full Text] [Related]
18. Tight junctions and enteropathogenic E. coli. Weflen AW; Alto NM; Hecht GA Ann N Y Acad Sci; 2009 May; 1165():169-74. PubMed ID: 19538303 [TBL] [Abstract][Full Text] [Related]
19. E. coli secreted protein F promotes EPEC invasion of intestinal epithelial cells via an SNX9-dependent mechanism. Weflen AW; Alto NM; Viswanathan VK; Hecht G Cell Microbiol; 2010 Jul; 12(7):919-29. PubMed ID: 20088948 [TBL] [Abstract][Full Text] [Related]
20. Generation of a MDCK cell line with constitutive expression of the Enteropathogenic E. coli effector protein Map as an in vitro model of pathogenesis. Singh AP; Aijaz S Bioengineered; 2015; 6(6):335-41. PubMed ID: 26430918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]